Interesting observation and which I similarly highlighted in my thread as well except that a more appropriate comparison ought to be 4DS also in chip category and has no revenues but a very big promise waiting to be validated . The difference is that 4DS trades at $77m market cap not $660m . I have no interest in both stocks . But yes BRN is trading at substantial premium to its progress to date and no business traction despite years in operation. BRN suffered a waterfall chart until March this year because it never delivered the promise when it was touted as a tech potential during tech stock boom of the 2017, so now in COVID ISO speculative frenzy , it's AI positioning came at the right time with another tech boom. The question is , is this time for real or another hype 2.0 in similar veins 3 years ago ? Incidentally Alex Waislitz owns both BRN and YOJ and both have been carrying big promises story with negligible almost zero revenues but a bloated share base.
- Forums
- ASX - By Stock
- BRN
- 30 cents, $0.3 next week
30 cents, $0.3 next week, page-191
-
- There are more pages in this discussion • 94 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $361.9M |
Open | High | Low | Value | Volume |
20.0¢ | 20.5¢ | 19.5¢ | $878.2K | 4.371M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
64 | 1444914 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 388739 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
62 | 1344164 | 0.195 |
62 | 1739410 | 0.190 |
33 | 1759832 | 0.185 |
50 | 1530443 | 0.180 |
16 | 598862 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 337097 | 7 |
0.205 | 914687 | 15 |
0.210 | 1398298 | 25 |
0.215 | 506951 | 23 |
0.220 | 758461 | 24 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online